FIELD: medicine. SUBSTANCE: described are diazepineindolederivatives of general formula I: 
wherein R and A are as defined in claims, racemic forms thereof, isomeric configurations thereof specified by carbon in position 3 of diazepineindol-4-one ring, and pharmacologically acceptable salts thereof which are phosphodiasterase-IV inhibitors, pharmaceutical compositions based thereon. Said compositions have higher activity with respect to phosphodiasterase-IV inhibition. EFFECT: improved properties of the title compounds. 12 cl, 9 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED N-PHENYLPYRROLIDINYL METHYLPYRROLIDINE AMIDES AND THERAPEUTIC USE THEREOF AS MODULATORS OF HISTAMINE H3 RECEPTOR | 2008 |
|
RU2477721C2 |
| DERIVATIVES OF DIAZEPINE, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF PATIENTS WITH ARRYTHMIA | 1994 |
|
RU2155587C2 |
| SUBSTITUTED N-PHENYLBIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF | 2008 |
|
RU2477719C2 |
| DERIVATIVES OF 1,5-BENZODIAZEPINE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION CONTAINING ON SAID | 1994 |
|
RU2135486C1 |
| 5-HETEROCYCLO-1,5-BENZODIAZEPINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1995 |
|
RU2152939C1 |
| ]1,4]DIAZEPINO[6,7,1-IJ]QUINOLINE DERIVATIVES USED AS ANTI-PSYCHOTIC AGENTS AND AGENTS AGAINST OBESITY | 2003 |
|
RU2312866C2 |
| PYRAZOLE DERIVATIVES APPLIED AS PROTEIN KINASE INHIBITORS | 2013 |
|
RU2623221C2 |
| PHENYLOXAZOLIDINONES HAVING C-C-BOND WITH 4-8-MEMBERED HETEROCYCLIC RINGS | 1996 |
|
RU2175324C2 |
| HETEROCYCLIC NITROGEN-CONTAINING DERIVATIVES OF CARBOXYLIC ACID, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2124503C1 |
| DERIVATIVES OF 4,1-BENZOXAZEPINE | 1993 |
|
RU2170732C2 |
